A randomized, single-blind, controlled trial to evaluate the effects of neural therapy on tinnitus severity, disability, and quality of life in patients with tinnitus. The study is planned to be conducted between December 2025 and March 2026. The sample size is 30 patients. The number of centers is 1. The study duration is 3 months.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Turkish version of the Tinnitus Disability Questionnaire (THI)
Timeframe: 3 months
SF-12 (short form)
Timeframe: 3 months
Tinnitus severity according to VAS (visual analog scale)
Timeframe: 3 months